The effect of rapamycin and its analogues on age-related musculoskeletal diseases: a systematic review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1720-8319
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effect of rapamycin and its analogues on age-related musculoskeletal diseases: a systematic review ; day:21 ; month:7 ; year:2022 ; pages:1-17
Aging clinical and experimental research ; (21.7.2022), 1-17
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40520-022-02190-0
- URN
-
urn:nbn:de:101:1-2022093022343179358327
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lin, Hong
- Salech, Felipe
- Lim, Anthony
- Vogrin, Sara
- Duque, Gustavo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effect of rapamycin on aging and age-related diseases—past and future
Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Applications of Lipidomics to Age-Related Musculoskeletal Disorders
Pathophysiology of age-related diseases
Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Immunosenescence and age-related viral diseases
Medical bioremediation of age-related diseases
MicroRNAs in age-related diseases
MicroRNAs in age‐related diseases
Work outcome in persons with musculoskeletal diseases: comparison with other chronic diseases & the role of musculoskeletal diseases in multimorbidity
Immuno (T) herapy for age‐related diseases
Cell‐Based Therapies for Degenerative Musculoskeletal Diseases
Effect of rapamycin on aging and age-related diseases—past and future
Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Applications of Lipidomics to Age-Related Musculoskeletal Disorders
Pathophysiology of age-related diseases
Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Immunosenescence and age-related viral diseases
Medical bioremediation of age-related diseases
MicroRNAs in age-related diseases
MicroRNAs in age‐related diseases
Work outcome in persons with musculoskeletal diseases: comparison with other chronic diseases & the role of musculoskeletal diseases in multimorbidity
Immuno (T) herapy for age‐related diseases
Cell‐Based Therapies for Degenerative Musculoskeletal Diseases
Effect of rapamycin on aging and age-related diseases—past and future
Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Applications of Lipidomics to Age-Related Musculoskeletal Disorders
Pathophysiology of age-related diseases
Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Immunosenescence and age-related viral diseases
Medical bioremediation of age-related diseases
MicroRNAs in age-related diseases
MicroRNAs in age‐related diseases
Work outcome in persons with musculoskeletal diseases: comparison with other chronic diseases & the role of musculoskeletal diseases in multimorbidity
Immuno (T) herapy for age‐related diseases